149 related articles for article (PubMed ID: 35525533)
1. Idiopathic Vitreomacular Traction Managed with Initial Observation: Clinical Course and Outcomes.
Patel V; Kiryakoza L; Chau V; Patel A; Yannuzzi NA; Flynn HW; Sridhar J
Ophthalmol Retina; 2022 Oct; 6(10):893-898. PubMed ID: 35525533
[TBL] [Abstract][Full Text] [Related]
2. Clinical Course of Vitreomacular Traction Managed Initially by Observation.
Tzu JH; John VJ; Flynn HW; Smiddy WE; Jackson JR; Isernhagen BA; Carver A; Leonard R; Tabandeh H; Boyer DS; Berrocal MH; Suzuki M; Freund KB; Gross JG
Ophthalmic Surg Lasers Imaging Retina; 2015 May; 46(5):571-6. PubMed ID: 26057761
[TBL] [Abstract][Full Text] [Related]
3. ANATOMICAL AND FUNCTIONAL OUTCOMES OF SYMPTOMATIC IDIOPATHIC VITREOMACULAR TRACTION: A Natural History Study From the Pan American Collaborative Retina Study Group.
Wu L; Zas M; Berrocal MH; Arevalo JF; Figueroa M; Rodriguez F; Serrano M; Graue F; Alezzandrini A; Gallego-Pinazo R; Roca JA; Iglicki M; Dalma-Weishauz J; Kozak I; Collado A; Badal J; Maia M; Salcedo-Villanueva G; Quiroz-Mercado H; Fromow-Guerra J; Lozano-Rechy D; Avila M; Chhablani J
Retina; 2016 Oct; 36(10):1913-8. PubMed ID: 26966868
[TBL] [Abstract][Full Text] [Related]
4. Long-term evaluation of vitreomacular traction disorder in spectral-domain optical coherence tomography.
Odrobina D; Michalewska Z; Michalewski J; Dzięgielewski K; Nawrocki J
Retina; 2011 Feb; 31(2):324-31. PubMed ID: 21416651
[TBL] [Abstract][Full Text] [Related]
5. Surgical Results in Ocriplasmin Candidates With Symptomatic Vitreomacular Traction Syndrome.
Vasquez DH; Altamirano JC; Casaus A; Del Valle RA; Gonzalez R; Gonzalez-De La Rosa A; Navarro-Partida J; Vasquez MA; Santos A
Curr Eye Res; 2018 Feb; 43(2):208-212. PubMed ID: 29111823
[TBL] [Abstract][Full Text] [Related]
6. PREDICTIVE FACTORS ASSOCIATED WITH THE VISUAL PROGNOSIS AFTER SURGERY FOR IDIOPATHIC VITREOMACULAR TRACTION.
Qi B; Yang X; Yu Y; Zhang K; Wu X; Wang X; Jia Q; Feng X; Liu W
Retina; 2024 Mar; 44(3):429-437. PubMed ID: 37883595
[TBL] [Abstract][Full Text] [Related]
7. Anatomical configurations of vitreomacular traction syndrome: influence on clinical course and surgical outcomes.
Lee EK; Lee SY; Lee JY; Heo JW; Yu HG; Chung H
Graefes Arch Clin Exp Ophthalmol; 2019 Aug; 257(8):1631-1639. PubMed ID: 31104140
[TBL] [Abstract][Full Text] [Related]
8. Subfoveal Lucency after Treatment of Vitreomacular Traction without Macular Hole in the Phase 3 Trials of Ocriplasmin Vitreolysis.
Thomas AS; Folgar FA; Jaffe GJ; Toth CA; Mahmoud TH
Ophthalmol Retina; 2019 Jan; 3(1):42-52. PubMed ID: 30929816
[TBL] [Abstract][Full Text] [Related]
9. PNEUMATIC VITREOLYSIS VERSUS PARS PLANA VITRECTOMY IN FOCAL SYMPTOMATIC VITREOMACULAR TRACTION SYNDROME: A Randomized Trial.
Kumar V; Sonkar R; Verma S; Azad SV; Chawla R; Venkatesh P; Vohra R; Kumar A
Retina; 2022 Jul; 42(7):1277-1283. PubMed ID: 35723920
[TBL] [Abstract][Full Text] [Related]
10. Vitreomacular traction in diabetic retinopathy.
Hsieh YT; Yang CM
Jpn J Ophthalmol; 2024 Jan; 68(1):12-18. PubMed ID: 38001367
[TBL] [Abstract][Full Text] [Related]
11. THE EFFECT OF ELECTIVE CATARACT EXTRACTION BY PHACOEMULSIFICATION IN EYES WITH VITREOMACULAR TRACTION SYNDROME.
Mantopoulos D; Prenner JL; Patel VK; Roth DB; Shah SP; Tsavaris O; Fine HF; Wheatley HM
Retina; 2021 Jan; 41(1):75-81. PubMed ID: 32106158
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of intravitreal ocriplasmin on vitreomacular traction and full-thickness macular holes.
Sharma P; Juhn A; Houston SK; Fineman M; Chiang A; Ho A; Regillo C
Am J Ophthalmol; 2015 May; 159(5):861-7.e2. PubMed ID: 25660387
[TBL] [Abstract][Full Text] [Related]
13. A retrospective cohort study in patients with tractional diseases of the vitreomacular interface (ReCoVit).
Stalmans P
Graefes Arch Clin Exp Ophthalmol; 2016 Apr; 254(4):617-28. PubMed ID: 26899900
[TBL] [Abstract][Full Text] [Related]
14. [Pharmaological vitreolysis with ocriplasmin as a treatment option for symptomatic focal vitreomacular traction with or without macular holes (≤400 μm) compared to tranconjunctival vitrectomy].
Maier M; Abraham S; Frank C; Lohmann CP; Feucht N
Ophthalmologe; 2017 Feb; 114(2):148-154. PubMed ID: 27444007
[TBL] [Abstract][Full Text] [Related]
15. Outer retina reflectivity changes on sd-oct after intravitreal ocriplasmin for vitreomacular traction and macular hole.
Quezada-Ruiz C; Pieramici DJ; Nasir M; Rabena M; Steinle N; Castellarin AA; Dhoot D; Couvillion S; See RF; Avery RL
Retina; 2015 Jun; 35(6):1144-50. PubMed ID: 25961122
[TBL] [Abstract][Full Text] [Related]
16. Vitreomacular traction quantitative cutoffs for the assessment of resolution after ocriplasmin intravitreal treatment.
Arrigo A; Calamuneri A; Bordato A; Aragona E; Pierro L; Bandello F; Battaglia Parodi M
Sci Rep; 2020 Oct; 10(1):17583. PubMed ID: 33067537
[TBL] [Abstract][Full Text] [Related]
17. Real-life experience after intravitreal ocriplasmin for vitreomacular traction and macular hole: a spectral-domain optical coherence tomography prospective study.
Chatziralli I; Theodossiadis G; Parikakis E; Datseris I; Theodossiadis P
Graefes Arch Clin Exp Ophthalmol; 2016 Feb; 254(2):223-33. PubMed ID: 25940555
[TBL] [Abstract][Full Text] [Related]
18. A novel spectral-domain optical coherence tomography model to estimate changes in vitreomacular traction syndrome.
Codenotti M; Iuliano L; Fogliato G; Querques G; Bandello F
Graefes Arch Clin Exp Ophthalmol; 2014 Nov; 252(11):1729-35. PubMed ID: 24764038
[TBL] [Abstract][Full Text] [Related]
19. Morphological Reconstitution and Persistent Changes After Intravitreal Ocriplasmin for Vitreomacular Traction and Macular Hole.
Zandi S; Freiberg F; Vaclavik V; Pfister IB; Traine PG; Kaya C; Michels S; Garweg JG
J Ocul Pharmacol Ther; 2020 Mar; 36(2):126-132. PubMed ID: 31934816
[No Abstract] [Full Text] [Related]
20. Ocriplasmin Treatment Leads to Symptomatic Vitreomacular Adhesion/Vitreomacular Traction Resolution in the Real-World Setting: The Phase IV ORBIT Study.
Khanani AM; Duker JS; Heier JS; Kaiser PK; Joondeph BC; Kozma P; Rosberger DF; MacCumber M; Boyer DS; Pieramici DJ
Ophthalmol Retina; 2019 Jan; 3(1):32-41. PubMed ID: 30935657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
